Daratumumab
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Daratumumab
Jul 21, 2024, 12:01 |
Insight
Myeloma Paper of the Day, July 21st, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: RPL5 loss, APOBEC mutagenesis, & gain…
Jun 20, 2024, 12:25 |
Insight
Luciano Costa: Some considerations on long-term follow-up of the CASSIOPEIA trial
Luciano Costa, a Professor at the University of Alabama at Birmingham, recently shared a post…
Jun 19, 2024, 09:28 |
Insight
Rafael Fonseca: Longer use of daratumumab results in better outcomes
Rafael Fonseca recently shared a post on X: "Long term CASSIOPEIA shows what was expected…
Jun 11, 2024, 12:59 |
Insight
Myeloma Paper of the Day, June 11th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Phase II trial of ixazomib/daratumumab/dexamethasone…
Jun 7, 2024, 16:50 |
Insight
Myeloma Paper of the Day, June 7th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Response rate and EFS to…
Jun 2, 2024, 15:31 |
Insight
Myeloma Paper of the Day, June 2nd, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: DREAMM-7 study shows belantamab/bortezomib/dexamethasone superior…
Jun 1, 2024, 02:42 |
Insight
Myeloma Paper of the Day, May 31st, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Phase II trial of Dara-KRd…
May 26, 2024, 14:20 |
Blog
C. Ola Landgren on Quadruple Therapies and the Future of Multiple Myeloma Treatment
Sylvester researcher C. Ola Landgren will present an overview of new studies and the state…
May 14, 2024, 16:12 |
Insight
Myeloma Paper of the Day, May 14th, suggester by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
May 6, 2024, 08:34 |
Insight
Manni Mohyuddin: Ten important observations about myeloma
Manni Mohyuddin shared a thread on X: . "Ten important observations about myeloma and its…
Apr 24, 2024, 13:27 |
Insight
Myeloma Paper of the Day, April 24th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
Apr 20, 2024, 05:56 |
Insight
Myeloma Paper of the Day suggested by Robert Orlowski, April 18th
Robert Orlowski, Director of the Myeloma Section at MD Anderson Cancer Center, shared on X:…
Mar 1, 2024, 18:37 |
Drugs
Vincent Rajkumar: How many years of life gained because of FDA accelerated approval in myeloma?
Vincent Rajkumar, Editor-in-Chief at the Blood Cancer Journal, shared a thread on X/Twitter: "How many…
Dec 23, 2023, 03:36 |
Blog
Vincent Rajkumar: Updated treatment approach to newly diagnosed myeloma based on new ASH 23 data
Vincent Rajkumar, Editor-in-Chief at Blood Cancer Journal, recently posted on X/Twitter: “Updated treatment approach to…
Sep 13, 2023, 15:27 |
Insight
Sophie Castell: DRD is a game changer and will make a tremendous difference to patients’ quality of life.
Sophie Castell, CEO of Myeloma UK, shared Myeloma UK's post on X/Twitter: "DRD is a…
Aug 7, 2023, 19:44 |
Drugs
This is a preventable tragedy- that we must avoid repeating - Manni Mohyuddin
Daratumumab has been known to be effective in relapsed myeloma for a long time. Yet…
All:
16
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube